Analysis of genomic variation in lung adenocarcinoma patients revealed the critical role of PI3K complex
Background Molecularly targeted therapies improved survival status of some patients with lung adenocarcinoma, which accounts for 40% of all lung cancers, and in-depth study of gene alterations is important for the personalized treatment. Methods The legacy archive data of clinical information and ge...
Main Authors: | Zhao min Deng, Lin Liu, Wen hai Qiu, Yong qun Zhang, Hong yan Zhong, Ping Liao, Yun hong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2017-05-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/3216.pdf |
Similar Items
-
PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma
by: Edge, S.D., et al.
Published: (2021) -
NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway
by: Zhang X, et al.
Published: (2020-11-01) -
Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma
by: Yuqiang Mao, et al.
Published: (2020-03-01) -
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
by: Talip Zengin, et al.
Published: (2020-09-01) -
Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma
by: Jun Zeng, et al.
Published: (2020-12-01)